EA200400096A1 - Применение корриноидов при кожных заболеваниях - Google Patents

Применение корриноидов при кожных заболеваниях

Info

Publication number
EA200400096A1
EA200400096A1 EA200400096A EA200400096A EA200400096A1 EA 200400096 A1 EA200400096 A1 EA 200400096A1 EA 200400096 A EA200400096 A EA 200400096A EA 200400096 A EA200400096 A EA 200400096A EA 200400096 A1 EA200400096 A1 EA 200400096A1
Authority
EA
Eurasian Patent Office
Prior art keywords
corrinoids
skin
application
skin diseases
improving
Prior art date
Application number
EA200400096A
Other languages
English (en)
Other versions
EA007592B1 (ru
Inventor
Карстен Клингельхеллер
Original Assignee
Регенерацио Фарма Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Регенерацио Фарма Аг filed Critical Регенерацио Фарма Аг
Publication of EA200400096A1 publication Critical patent/EA200400096A1/ru
Publication of EA007592B1 publication Critical patent/EA007592B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Описано применение соединений формулы I, в которой R означает CN, OH, CHили HO, для восстановления и улучшения сопротивляемости кожи. Соединения особенно пригодны для профилактики предрасположенности к хроническим кожным заболеваниям, для профилактики и лечения аллергических кожных реакций, для лечения острых кожных повреждений, например, при ожогах и ранах, а также при старении кожи, и для лечения вырожденных клеток, как при карциноматозе, доброкачественных и/или злокачественных опухолях.Отчет о международном поиске был опубликован 2003.03.20.
EA200400096A 2001-06-28 2002-06-26 Применение корриноидов при кожных заболеваниях EA007592B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10130846A DE10130846A1 (de) 2001-06-28 2001-06-28 Verwendung von Corrinoiden zur Anwendung bei Hauterkrankungen
PCT/EP2002/007067 WO2003002104A2 (de) 2001-06-28 2002-06-26 Verwendung von corrinoiden zur anwendung bei hauterkrankungen

Publications (2)

Publication Number Publication Date
EA200400096A1 true EA200400096A1 (ru) 2004-04-29
EA007592B1 EA007592B1 (ru) 2006-12-29

Family

ID=7689544

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400096A EA007592B1 (ru) 2001-06-28 2002-06-26 Применение корриноидов при кожных заболеваниях

Country Status (17)

Country Link
US (3) US20040171578A1 (ru)
EP (4) EP1401454A2 (ru)
JP (1) JP2004535440A (ru)
KR (1) KR20040019315A (ru)
CN (1) CN1325057C (ru)
AT (1) ATE520407T1 (ru)
AU (1) AU2002352566B2 (ru)
BR (1) BR0210672A (ru)
CA (1) CA2451579A1 (ru)
DE (1) DE10130846A1 (ru)
EA (1) EA007592B1 (ru)
ES (1) ES2371739T3 (ru)
IL (1) IL159070A0 (ru)
MX (1) MXPA03011810A (ru)
NZ (1) NZ529912A (ru)
WO (1) WO2003002104A2 (ru)
ZA (1) ZA200309976B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006054757A1 (ja) * 2004-11-16 2008-06-05 アステラス製薬株式会社 カスパーゼ阻害剤
DE102005001645A1 (de) * 2005-01-13 2006-07-20 Gerhard Dr. Sauermann Topisches Produkt zur Vorbeugung und Behandlung von Windeldermatitis
NL1032238C2 (nl) * 2006-07-27 2008-01-29 Marie Louise Koskamp Toepassing van een vorm van vitamine B12 voor de bereiding van een samenstelling voor het repareren van DNA en voor de bereiding van een samenstelling voor het therapeutisch of profylactisch genezen van neurofibromatose.
EP2322188A1 (en) * 2009-10-28 2011-05-18 Bodo Melnik Treatment of Inflammatory and Hyperproliferative Skin disease
DE102010023324A1 (de) * 2010-06-10 2011-12-15 Thomas Schütz Verwendung von Corrinoiden zur kosmetischen Anwendung bei gesundem Fell bzw. gesunder Haut, sowie zur kosmetischen Pflege bei Fell- und Hauterkrankungen bei Klein- und Groß-Tieren (warm- und kaltblütig), (z.B. bei Fischen, Vögeln, Pferden, Rindern, Kamelen, Hunden Katzen, Reptilien)
DE102010023626A1 (de) * 2010-06-14 2011-12-15 Thomas Schütz Verwendung von Corrinoiden zur arzneilichen Anwendung bei Fell- und Hauterkrankungen bei Klein- und Groß-Tieren (warm- und kaltblütig), (z.B. bei Fischen, Vögeln, Pferden, Rindern, Kamelen, Hunden, Katzen, Reptilien)
US11147761B2 (en) * 2018-01-12 2021-10-19 Nicole Akmenkalns Topical supplement composition and method of use
EP4201410A1 (en) * 2021-12-21 2023-06-28 DSM IP Assets B.V. Novel use of vitamin b12
EP4201411A1 (en) * 2021-12-21 2023-06-28 DSM IP Assets B.V. Novel use of vitamin b12

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7695M (ru) * 1968-05-03 1970-02-23
US4007266A (en) * 1968-05-03 1977-02-08 Choay S.A. Pharmaceutical composition containing vitamin B12, process of making the same and method of treatment
DE2325809A1 (de) * 1973-05-22 1974-12-19 8702 Gerbrunn Hautmittel
DE2505114C3 (de) * 1975-02-07 1979-06-13 Valentin Dr.Med. Koehler Kopfhautpflegemlttel
NZ195881A (en) * 1980-12-19 1984-08-24 W Lysaght Pharmaceutical compositions containing cobalt compounds
DE3210669A1 (de) * 1982-03-23 1983-09-29 Hrvoje Dr. Zagreb Krnjević Pharmazeutisches mittel zur behandlung von hautkrankheiten, schleimhauterkrankungen und nagelwuchsstoerungen
NL9101406A (nl) * 1991-08-20 1993-03-16 Vunderink Ate Werkwijze voor de bestrijding en preventie van ziekten die door micro-organismen veroorzaakt worden.
US6110472A (en) * 1992-12-10 2000-08-29 Hemogen Inc. Vitamin B12 containing scalp and skin treatment compositions
AU680222B2 (en) * 1992-12-10 1997-07-24 Hemogen, Inc. Method for stimulating production of heme oxygenase using vitamin B12
DE4319629A1 (de) 1993-06-15 1994-12-22 Karsten Klingelhoeller Verwendung von Corrinoiden zur topischen Anwendung bei Hauterkrankungen
US6194452B1 (en) * 1997-11-07 2001-02-27 Howard Murad Stable pharmaceutical compositions including ascorbic acid and methods of using same
US6117119A (en) * 1998-08-28 2000-09-12 Silipos, Inc. Gelatinous body protection article having a therapeutic additive
CA2313659A1 (en) * 2000-07-06 2002-01-06 Barry J. Barclay B complex vitamin compositions that protect against cellular damage caused by ultraviolet light

Also Published As

Publication number Publication date
NZ529912A (en) 2006-09-29
ES2371739T3 (es) 2012-01-09
CN1325057C (zh) 2007-07-11
IL159070A0 (en) 2004-05-12
AU2002352566B2 (en) 2007-06-14
US20060094686A1 (en) 2006-05-04
MXPA03011810A (es) 2005-03-07
ZA200309976B (en) 2004-09-17
EP2198871A1 (de) 2010-06-23
WO2003002104A2 (de) 2003-01-09
EP2198871B1 (de) 2011-08-17
EP2193796A1 (de) 2010-06-09
DE10130846A1 (de) 2003-01-16
WO2003002104A3 (de) 2003-03-20
EA007592B1 (ru) 2006-12-29
EP2198872A1 (de) 2010-06-23
ATE520407T1 (de) 2011-09-15
CN1688319A (zh) 2005-10-26
KR20040019315A (ko) 2004-03-05
EP1401454A2 (de) 2004-03-31
JP2004535440A (ja) 2004-11-25
BR0210672A (pt) 2004-10-13
US20040171578A1 (en) 2004-09-02
US20070129325A1 (en) 2007-06-07
CA2451579A1 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
NO20002440L (no) Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
ATE168373T1 (de) Benzofuranyl- und thiophenylalkancarbonsäurederivate
WO2002053101A3 (en) Method for treating fibrotic diseases or other indications
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
TR200100672T2 (tr) Yeni izoksazolinon antibakteriyel ajanları
DK0952148T3 (da) Cyclobutylaryloxyarylsulfonylaminohydroxamsyrederivater
EA200400096A1 (ru) Применение корриноидов при кожных заболеваниях
ATE88478T1 (de) 3'-deamino-4'-deoxy-4'-aminoanthracycline.
BR9916096A (pt) Derivados de bacterioclorofila substituìdos compaládio e utilização dos mesmos
ATE115541T1 (de) Benzyloxyphenylderivate.
ATE246180T1 (de) Benzofuranon-derivate und verfahren zu ihrer herstellung
DE59001281D1 (de) Oxidierte diphenylheteroalkane, ihre herstellung und verwendung.
AU8213487A (en) Anthracycline derivatives having cytostatic activity
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
FI945458A0 (fi) Parannettuja antiandrogeenejä
AU5508290A (en) 3-Butenamide derivatives
BR9910185A (pt) Uso de um composto, e, processo para o tratamento de um paciente que sofre de, ou em risco de, uma doença micobacteriana
ES2134563T3 (es) Cianofenilsulfenil halogenuro y su utilizacion en el procedimiento de preparacion de benzoisotiazol 3-sustituido.
ES2123741T3 (es) Derivados de bencimidazol, su preparacion y uso.
EA199900723A1 (ru) Производные феноксиуксусной кислоты и их применение в качестве гербицидов
ATE277614T1 (de) Anxiolytischer wirkstoff
DE69828638D1 (de) Hydroxam- und carbonsäurederivate mit mmp- und tnf-hemmender aktivität
BR0316059A (pt) Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise
DK1030842T3 (da) Metalloproteinaseinhibitorer

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY MD RU